Sharper radiation beams aim to tame High-Risk prostate cancer
NCT ID NCT02177292
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a newer, highly precise radiation technique for men with high-risk prostate cancer. The treatment delivers a strong dose to the pelvic lymph nodes while boosting radiation to the prostate itself. Researchers want to see if this approach controls the cancer better and causes fewer side effects than standard radiation. The trial enrolled 80 participants and is no longer recruiting.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Intensity Modulated Radiation Therapy (IMRT) and Image Guided Radiation Therapy (IGRT)
What this could lead to
If successful, this approach could offer a more effective and precise radiation treatment for high-risk prostate cancer, potentially improving disease control and reducing side effects.
What could go wrong
This is a small, early-phase trial (80 people) with no comparison group, so results may not apply to all patients. Radiation can still cause side effects like bowel or bladder issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Froedtert & the Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States